Dolby Laboratories, Inc. — Q1 FY2023 Form 10-Q
Reporting period: Fiscal quarter ended December 30, 2022 (13 weeks), compared with the quarter ended December 31, 2021 (14 weeks). Amounts below are in U.S. dollars; financial statement figures are converted from thousands to millions where appropriate. The different quarter lengths limit direct year-over-year comparability.
Financial performance and position
| Metric | Q1 FY2023 | Prior period | Change / context |
|---|---|---|---|
| Revenue | $334.9 million | $351.6 million | Down 4.7%; prior period included one additional week |
| Licensing revenue | $308.0 million | $332.3 million | Down 7%; 92% of total revenue |
| Products and services revenue | $26.9 million | $19.3 million | Up 39% |
| Gross margin | $300.5 million; 89.7% | $318.9 million; 90.7% | Gross margin dollars declined; product and services mix improved |
| Operating expenses | $206.4 million | $228.3 million | Down 10% |
| Operating income | $94.1 million | $90.6 million | Operating margin approximately 28.1%, versus 25.8% |
| Net income attributable to Dolby | $79.4 million | $80.0 million | Down 0.8% |
| Diluted EPS | $0.82 | $0.77 | Higher despite slightly lower net income; diluted weighted-average shares fell to 97.0 million from 103.8 million |
| Operating cash flow | $56.4 million | $31.7 million | Up $24.7 million |
| Capital expenditures | $7.2 million | $14.5 million | Calculated operating cash flow less capital expenditures was $49.2 million, versus $17.2 million |
| Cash, cash equivalents and investments | $883.1 million | $911.9 million at September 30, 2022 | Includes $626.2 million cash and equivalents and $256.9 million short- and long-term investments |
| Working capital | $1,059.0 million | $1,033.4 million at September 30, 2022 | Strong reported short-term liquidity |
Debt and liabilities: The supplied balance sheet does not show a borrowings balance or a clear total debt figure. Total liabilities were $456.0 million, including $47.4 million of operating lease liabilities and $45.1 million of contract liabilities. Interest expense was $0.1 million. Management said available liquidity and operating cash flows should meet anticipated cash requirements for at least the next 12 months.
Material changes and management commentary
- Licensing revenue declined across several markets: mobile revenue was $64.3 million, down from $74.9 million; PC was $24.3 million, down from $34.8 million; and broadcast was $117.3 million, down from $121.6 million. Management cited prior-year minimum-volume transactions and recoveries, lower unit shipments, and lower recoveries; higher adoption of Dolby Vision and Atmos partly offset some declines.
- Products and services revenue increased as demand for cinema equipment improved with the exhibitor market’s recovery. Product gross margin also benefited from lower excess and obsolescence charges and lower manufacturing spend. Dolby.io revenue increased, partly offset by lower cinema production services revenue.
- First-quarter licensing revenue included an approximately $10 million favorable adjustment, primarily related to July–September shipments and actual royalty statements. Recoveries and royalty estimates can fluctuate between quarters.
- Research and development expense fell 6%, sales and marketing fell 15%, and general and administrative expense fell 4%. Management attributed reductions in part to lower headcount, lower prior-period marketing activity, and lower credit-loss expense. The comparison also reflects the prior-year quarter’s extra week.
- Other income rose to $5.9 million from $0.9 million, mainly because of higher interest income from increased rates. The effective tax rate increased to 20.5% from 12.5%, principally due to earnings mix and lower tax benefits related to stock-based award settlements.
- Dolby repurchased 680,861 shares for $49.4 million during the quarter and paid a $0.27-per-share dividend. Remaining repurchase authorization was $311.4 million at December 30, 2022. The company noted a new 1% U.S. excise tax on certain stock buybacks and was assessing its impact.
Outlook, risks and contingencies
- The filing provides no specific quarterly or full-year revenue or earnings guidance in the supplied text. Management described macroeconomic uncertainty as substantial and said its effects on the business and financial position remained uncertain.
- Management cited inflation, higher interest rates, reduced discretionary spending, supply-chain and semiconductor constraints, shipping costs, COVID-19 effects, and international conflicts as factors that may reduce device demand, delay shipments and launches, slow technology adoption, and hinder collections or royalty recoveries.
- Business performance depends substantially on licensee shipments and accurate royalty reporting. Licensing agreements generally do not require minimum purchases, and technology adoption can vary with consumer demand, competition, industry standards, and the availability of content in Dolby formats.
- Cinema revenue remains exposed to box-office performance, exhibitor financial health, capacity restrictions, and the pace of cinema recovery. Dolby reported more than 280 open Dolby Cinema sites and five openings in the quarter.
- Legal proceedings arise in the ordinary course, including IP-related matters. Management did not expect them to have a material adverse impact based on information available, while noting an unfavorable resolution could affect results in a particular period. The company said some indemnification exposure cannot be reasonably estimated.
- Contractual commitments totaled $152.2 million, primarily naming rights ($100.7 million) and purchase obligations ($48.9 million). Gross unrecognized tax benefits were $72.9 million, up from $69.7 million at September 30, 2022; $53.0 million would reduce the effective tax rate if recognized.
- The Dolby family and affiliates held approximately 85.7% of combined voting power at December 30, 2022, reflecting the ten-votes-per-share Class B structure. This gives them substantial influence over matters requiring stockholder approval.
Important facts for investors to verify
- How much of the licensing decline reflects the shorter reporting quarter versus lower underlying shipments, and whether shipment trends improve.
- The size, timing, and repeatability of royalty recoveries and favorable true-ups, including the approximately $10 million Q1 adjustment.
- Whether cinema attendance, equipment demand, and Dolby Cinema box-office receipts continue to recover, and the effect of supply constraints on product deliveries.
- Cash conversion and working-capital movements, particularly increases in accounts receivable and contract assets, alongside the reported improvement in operating cash flow.
- The effect of macroeconomic conditions, tax-rate changes, unrecognized tax benefits, and the stock-buyback excise tax on future results and capital returns.
- Developments in legal, IP, regulatory, and indemnification matters, and any changes in the controlling stockholder’s voting position.